Abstract
Cardiometabolic problems in children with human immunodeficiency virus (HIV) infection have recently begun to emerge as distinct clinical problems that require monitoring and often intervention. The cardiometabolic issues that face HIV-infected children include high rates of unfavorable lipid profiles, insulin resistance, cardiovascular inflammation, and vascular stiffness as well as the phenotypic features of truncal adiposity and facial/extremity wasting. Children differ from adults in that many have been exposed to both HIV and antiretroviral therapies even before birth. The future risk of adverse cardiovascular outcomes is poorly defined yet warrants close tracking because a number of risk factors are present in early childhood. Preventive care and interventions that include surveillance of nutrition and body composition, dietary counseling, exercise programs, and drug therapy should be considered standard care for all HIV-infected children.
| Original language | English |
|---|---|
| Pages (from-to) | 98-105 |
| Number of pages | 8 |
| Journal | Journal of the CardioMetabolic Syndrome |
| Volume | 3 |
| Issue number | 2 |
| State | Published - Mar 1 2008 |
Fingerprint
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
Cite this
Cardiometabolic disease in human immunodeficiency virus-infected children. / Miller, Tracie L; Grant, Yoran T.; Almeida, Daniela Neri; Sharma, Tanvi; Lipshultz, Steven E.
In: Journal of the CardioMetabolic Syndrome, Vol. 3, No. 2, 01.03.2008, p. 98-105.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cardiometabolic disease in human immunodeficiency virus-infected children.
AU - Miller, Tracie L
AU - Grant, Yoran T.
AU - Almeida, Daniela Neri
AU - Sharma, Tanvi
AU - Lipshultz, Steven E
PY - 2008/3/1
Y1 - 2008/3/1
N2 - Cardiometabolic problems in children with human immunodeficiency virus (HIV) infection have recently begun to emerge as distinct clinical problems that require monitoring and often intervention. The cardiometabolic issues that face HIV-infected children include high rates of unfavorable lipid profiles, insulin resistance, cardiovascular inflammation, and vascular stiffness as well as the phenotypic features of truncal adiposity and facial/extremity wasting. Children differ from adults in that many have been exposed to both HIV and antiretroviral therapies even before birth. The future risk of adverse cardiovascular outcomes is poorly defined yet warrants close tracking because a number of risk factors are present in early childhood. Preventive care and interventions that include surveillance of nutrition and body composition, dietary counseling, exercise programs, and drug therapy should be considered standard care for all HIV-infected children.
AB - Cardiometabolic problems in children with human immunodeficiency virus (HIV) infection have recently begun to emerge as distinct clinical problems that require monitoring and often intervention. The cardiometabolic issues that face HIV-infected children include high rates of unfavorable lipid profiles, insulin resistance, cardiovascular inflammation, and vascular stiffness as well as the phenotypic features of truncal adiposity and facial/extremity wasting. Children differ from adults in that many have been exposed to both HIV and antiretroviral therapies even before birth. The future risk of adverse cardiovascular outcomes is poorly defined yet warrants close tracking because a number of risk factors are present in early childhood. Preventive care and interventions that include surveillance of nutrition and body composition, dietary counseling, exercise programs, and drug therapy should be considered standard care for all HIV-infected children.
UR - http://www.scopus.com/inward/record.url?scp=65849281086&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65849281086&partnerID=8YFLogxK
M3 - Article
C2 - 18453810
AN - SCOPUS:65849281086
VL - 3
SP - 98
EP - 105
JO - Journal of the CardioMetabolic Syndrome
JF - Journal of the CardioMetabolic Syndrome
SN - 1559-4564
IS - 2
ER -